SEC Form 4 · accession 0001209191-16-108682
Fluent, Inc. · FLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Mar 11, 2016
Accepted (ET)
Mar 15, 2016 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460329
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 11, 2016 | A | 900,108 | — | A | 12,873,223 | I | By Frost Gamma Investments Trust |
| Common StockF3,F2 | Mar 11, 2016 | C | 524,750 | — | A | 13,397,973 | I | By Frost Gamma Investments Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF2,F3 | — | Mar 11, 2016 | C | 524,750 | D | — | — | Common Stock | 524,750 | 0 | I |
Explanation of responses
- F1The shares of Common Stock were issued as earn-out consideration in connection with that certain Merger Agreement and Plan of Reorganization dated as of December 14, 2014, as amended, to which the Company is a party.
- F2These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F3The shares of Common Stock were issued in exchange for the surrender of a warrant to purchase Common Stock, with one share of Common Stock issued for each share of Common Stock available for purchase under such warrant.